Dog Aging Project
Evaluation of a low-technology system to obtain morphological and mobility trial measurements in dogs and investigations of potential predictors of canine mobility
Morgan EM, Heseltine JC, Levine GJ, Promislow DEL, Creevy KE.
How veterinary biobanking provides opportunities to accelerate research
Castelhano MG, Creevy KE, Mullins PF.
Canine hyperadrenocorticism associations with signalment, selected comorbidities and mortality within North American veterinary teaching hospitals.
Hoffman JM, Lourenço BN, Promislow DEL, Creevy KE.
Research to Promote Longevity and Health Span in Companion Dogs: A Pediatric Perspective.
Wilfond BS, Porter KM, Creevy KE, Kaeberlein M, Promislow D.
The companion dog as a model for human aging and mortality.
Hoffman JM, Creevy KE, Franks A, O'Neill DG, Promislow DEL.
Oral health in geroscience: animal models and the aging oral cavity
An, JY, Darveau R, Kaeberlein M.
Do Female Dogs Age Differently Than Male Dogs?
Hoffman JM, O'Neill DG, Creevy KE, Austad SN.
Translational Geroscience: From invertebrate models to companion animal and human interventions
Lee MB, Kaeberlein M.
A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs.
Urfer SR, Kaeberlein TL, Mailheau S, Bergman PJ, Creevy KE, Promislow DEL, Kaeberlein M.
Asymptomatic heart valve dysfunction in healthy middle-aged companion dogs and its implications for cardiac aging.
Urfer SR, Kaeberlein TL, Mailheau S, Bergman PJ, Creevy KE, Promislow DE, Kaeberlein M.
Multiple morbidities in companion dogs: a novel model for investigating age-related disease.
Jin K, Hoffman JM, Creevy KE, O'Neill DG, Promislow DE.
The dog aging project: translational geroscience in companion animals.
Kaeberlein M, Creevy KE, Promislow DE.